Valeant Licenses Epilepsy Drug to GSK
By Taskin Ahmed
Pharma Deals Review: Vol 2008 Issue 99 (Table of Contents)
Published: 28 Aug-2008
DOI: 10.3833/pdr.v2008.i99.141 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
GlaxoSmithKline has agreed to license in the epilepsy drug, retigabine, in a deal that could be as much as US$820 M to Valeant Pharmaceuticals...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS